Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
Neurol Sci
.
2021 Nov;42(11):4433-4435.
doi: 10.1007/s10072-021-05543-1.
Epub 2021 Aug 11.
Authors
Kazuyuki Saito
1
,
Taro Shimizu
2
,
Katsue Suzuki-Inoue
3
,
Tatsuhiro Ishida
2
,
Yoshiaki Wada
4
Affiliations
1
Department of Neurology, Nissan Tamagawa Hospital, Seta 4-8-1, Setagaya, Tokyo, 158-0095, Japan. kaz_saito228@yahoo.co.jp.
2
Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan.
3
Department of Clinical and Laboratory Medicine, Faculty of Medicine, Yamanashi University, Yamanashi, Japan.
4
Department of Neurology, Nissan Tamagawa Hospital, Seta 4-8-1, Setagaya, Tokyo, 158-0095, Japan.
PMID:
34378098
PMCID:
PMC8354782
DOI:
10.1007/s10072-021-05543-1
No abstract available
Publication types
Letter
MeSH terms
BNT162 Vaccine
COVID-19 / prevention & control
COVID-19 Vaccines* / adverse effects
Humans
Meningitis, Aseptic* / etiology
Vaccination* / adverse effects
Substances
COVID-19 Vaccines
BNT162 Vaccine